To further understand the mechanism whereby SN38 in combination with ATM inhibition facilitates anti-proliferative effects and G2/M cell cycle arrest, we examined treatment effects on the ATM pathway by immunoblotting in the combination sensitive (RKO) and combination resistant (LS123) CRC cell lines. Here, ATM is linked to colorectal carcinoma.